Polyphenolic compounds are very strong Inhibitors of non-heme iron absorption, as they form insoluble complexes with ferrous iron. Patients with hereditary hemochromatosis (HH) have an increased intestinal non-heme iron absorption due to a genetic mutation in the regulatory pathway, leading to excess iron in the body. This study investigates the inhibitory effect of a natural polyphenol Supplement in participants with HH.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
SINGLE
Enrollment
14
Test meal consumed with the natural polyphenol supplement
Test meal consumed with the control supplement
Test drink consumed with the natural polyphenol supplement
Test drink consumed with the control supplement
Porto University Hospital Center
Porto, Portugal
Laboratory of Human Nutrition ETH Zurich
Zurich, Switzerland
change from baseline in the isotopic ratio of iron in blood at week 2
The change in the isotopic ratio of iron will be measured after administration of a test meal/drink including iron isotopes
Time frame: baseline, 2 weeks
change from baseline in the isotopic ratio of iron in blood at week 4
The change in the isotopic ratio of iron will be measured after administration of a test meal/drink including iron isotopes
Time frame: 2 weeks, 4 weeks
Serum Ferritin concentration (µg/L)
to assess iron status
Time frame: baseline, weeks 2, and 4
Serum iron concentration (µg/dL)
to assess iron status
Time frame: baseline, weeks 2, and 4
Soluble transferrin receptor (mg/L)
to assess iron status
Time frame: baseline, weeks 2, and 4
Transferrin saturation in %
to calculate percent of transferrin that has iron bound to it; Plasma iron and transferrin saturation will be combined to calculate transferrin saturation (ratio)
Time frame: baseline, weeks 2, and 4
Hemoglobin (g/dL)
to assess blood volume based on weight, height, and Hb.
Time frame: baseline, weeks 2, and 4
C-reactive Protein (mg/L)
identify acute inflammation
Time frame: baseline, weeks 2, and 4
alpha-1-glycoprotein (g/L)
identify chronic inflammation
Time frame: baseline, weeks 2, and 4
Serum Hepcidin (nM)
the major regulator of non-heme iron absorption
Time frame: baseline, and weeks 2
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.